WHO ICTRP trial
Non-interventional study X-TRA Safety and efficacy of safinamide (Xadago®) as…
DRKS00009032 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00009032 |
|---|---|
| Public title | Non-interventional study X-TRA Safety and efficacy of safinamide (Xadago®) as add-on therapy to levodopa in mid- to late-stage Parkinson’s disease patients – a non-interventional observational study in daily practice of German neurologists |
| Scientific title | Non-interventional study X-TRA Safety and efficacy of safinamide (Xadago®) as add-on therapy to levodopa in mid- to late-stage Parkinson’s disease patients – a non-interventional observational study in daily practice of German neurologists - X-TRA |
| Primary sponsor | Zambon GmbH |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | G20;Parkinson disease |
| Interventions | Group 1: Since this is a non-interventional study, the treatment of patients with Xadago® is carried out according to the current summary of product characteristics within the approved indication. Patients must give their consent to the… |
| Registration date | Aug 19, 2015 |
| Target size | 2500 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: